MIDWEST BIOPROCESSING CENTER LLC
1 known investors
Midwest Bioprocessing Center develops biobased ingredients for the cosmetics and skin care industry, including its FeruliShield hemp-derived ingredient. It focuses on transparent, biobased inputs for clean beauty products.
BiotechConsumerNew Materials
Investors · 1
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $930.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $217.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $193.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does MIDWEST BIOPROCESSING CENTER LLC do?
- Midwest Bioprocessing Center develops biobased ingredients for the cosmetics and skin care industry, including its FeruliShield hemp-derived ingredient. It focuses on transparent, biobased inputs for clean beauty products.
- Who are MIDWEST BIOPROCESSING CENTER LLC's investors?
- MIDWEST BIOPROCESSING CENTER LLC's investors include gener8tor.